Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model

다국어 초록 (Multilingual Abstract)

The purpose of our study was to create a novel rat aorta stent implantation model. Stainless steel bare metal stents (BMS) or paclitaxel-eluting stents (PES) were implanted in male Sprague-Dawley rats (BW 400 ± 20 g). Two and four weeks after stent implantation, the aorta were collected, fixed with 2% glutaraldehyde, and cut into two segments. One segment was used for scanning electron microscopy analysis to evaluate re-endothelialization, and the other segment was used to calculate the neointimal area. At 2 weeks after stenting, the appearance of neointimal hyperplasia was less in the PES group than in the BMS group. At 4 weeks after stenting, no significant difference in neointimal hyperplasia was observed between two groups. On the other hand, the PES group showed more thrombus formation and less re-endothelialization compared to the BMS group. This study demonstrated the ability of a novel rat model of aorta stenting via a common carotid artery to measure the efficacy and safety of commercially available drug-eluting stents.

참고문헌 (Reference)

1 Lagerqvist B, "the SCAAR Study Group. Long-term outcomes with drug-Eluting stents versus Bare-Metal stents in Sweden" 356 : 1009-1019, 2007

2 Finn AV, "Vascular responses to drug eluting stents: importance of delayed healing" 27 : 1500-1510, 2007

3 Maisel WH, "Unanswered questions - Drug-eluting stents and the risk of late thrombosis" 356 : 981-984, 2007

4 Johnson GJ, "The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis" 81 : 835-843, 1999

5 Suzuki T, "Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model" 104 : 1188-1193, 2001

6 Farb A, "Stent thrombosis redux - The FDA perspective" 356 : 984-987, 2007

7 Mauri L, "Stent thrombosis in randomized clinical trials of drug-Eluting stents" 356 : 1020-1029, 2007

8 Stone GW, "Safety and efficacy of sirolimus- and paclitaxeleluting coronary stents" 356 : 998-1008, 2007

9 Langeveld B, "Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis" 41 : 377-386, 2004

10 Finn AV, "Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization" 115 : 2435-2441, 2007

11 Drachman DE, "Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months" 36 : 2325-2332, 2000

12 Ertas G, "Late stent thrombosis, endothelialisation and drug-eluting stents" 17 : 177-180, 2009

13 Gallo R, "Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle" 99 : 2164-2170, 1999

14 Lim SY, "Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis" 72 : 463-468, 2008

15 Kotani J, "Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings" 47 : 2108-2111, 2006

16 Suzuki Y, "In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation" 1 : 168-173, 2008

17 Alhan C, "Endovascular treatment of occlusive abdominal aortic thrombosis" 25 : 70-72, 2010

18 서원희, "Effects of Curcumin for Preventing Restenosis in a Hypercholesterolemic Rabbit Iliac Artery Stent Model" wiley interscience 74 : 881-888, 2009

19 Curfman GD, "Drug-eluting coronary stents - Promise and uncertainty" 356 : 1059-1060, 2007

20 Virmani R, "Drug eluting stents: are human and animal studies comparable" 89 : 133-138, 2003

21 Finn AV, "Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents" 112 : 270-278, 2005

22 Busseuil D, "Combining sirolimus-eluting stents and external irradiation in cholesterolfed rabbits increased incomplete stent apposition and decreased re-endothelialization" 53 : 318-324, 2009

23 Kastrati A, "Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents" 356 : 1030-1039, 2007

24 Li J, "Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents" 1 : 279-285, 2008

25 Spaulding C, "A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents" 356 : 989-997, 2007

26 Park SJ, "A paclitaxel-eluting stent for the prevention of coronary restenosis" 348 : 1537-1545, 2003

27 Finn AV, "A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases" 39 : 414-425, 2002

28 Palombini L, "A new rat model of small vessel stenting" 95 : 179-185, 2000